The Impact of Drug Shortages on Children with Cancer — The Example of Mechlorethamine

Monika L. Metzger · Amy Louise Billett · Michael Paul Link

101 citations0/0 files storedNew England Journal of Medicine

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Pharmaceutical studies and practices Economic and Financial Impacts of Cancer

Abstract

Interview with Dr. Bruce Chabner on shortages of generic drugs and possible solutions. (10:16)Download Among the generic drugs in short supply is mechlorethamine, part of a standard regimen for pediatric Hodgkin's lymphoma. The Pediatric Hodgkin Lymphoma Consortium has substituted cyclophosphamide, which is less effective and increases the risk of complications.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 101 citations exist upstream.

References

2011The Shortage of Essential Chemotherapy Drugs in the United States

Cited by

2020The Drug Shortage Era: A Scoping Review of the Literature 2001–2019 2017Ensuring Access to Injectable Generic Drugs — The Case of Intravesical BCG for Bladder Cancer

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.